CHF531.00
0.53% day before yesterday
SIX Swiss Exchange, Dec 20, 05:30 pm CET
ISIN
CH0013841017
Symbol
LONN
Sector
Industry

Lonza Stock price

CHF531.00
+14.00 2.71% 1M
+50.40 10.49% 6M
+177.30 50.13% YTD
+185.70 53.78% 1Y
-221.20 29.41% 3Y
+178.40 50.60% 5Y
+428.09 415.98% 10Y
SIX Swiss Exchange, Closing price Fri, Dec 20 2024
+2.80 0.53%
ISIN
CH0013841017
Symbol
LONN
Sector
Industry

Key metrics

Market capitalization CHF36.56b
Enterprise Value CHF38.40b
P/E (TTM) P/E ratio 65.06
EV/FCF (TTM) EV/FCF 816.96
EV/Sales (TTM) EV/Sales 5.73
P/S ratio (TTM) P/S ratio 5.46
P/B ratio (TTM) P/B ratio 3.91
Dividend yield 0.75%
Last dividend (FY23) CHF4.00
Revenue growth (TTM) Revenue growth 5.97%
Revenue (TTM) Revenue CHF6.70b
EBIT (operating result TTM) EBIT CHF1.43b
Free Cash Flow (TTM) Free Cash Flow CHF47.00m
EPS (TTM) EPS CHF8.16
P/E forward 45.51
P/S forward 5.56
EV/Sales forward 5.84
Show more

Create a Free Account to create an Lonza alert.

Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.

Lonza Stock Analysis

Analyst Opinions

24 Analysts have issued a Lonza forecast:

22x Buy
92%
2x Hold
8%

Analyst Opinions

24 Analysts have issued a Lonza forecast:

Buy
92%
Hold
8%

Financial data from Lonza

Income Statement P&L | Balance Sheet | Cash Flow


TTM Annually
Jun '24
+/-
%
6,696 6,696
6% 6%
100%
- Direct Costs 4,740 4,740
19% 19%
71%
1,956 1,956
17% 17%
29%
- Selling and Administrative Expenses - -
- Research and Development Expense - -
-
-
2,064 2,064
2% 2%
31%
- Depreciation and Amortization 631 631
4% 4%
9%
EBIT (Operating Income) EBIT 1,433 1,433
5% 5%
21%
Net Profit 573 573
49% 49%
9%

In millions CHF.

Don't miss a Thing! We will send you all news about Lonza directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Lonza Stock News

marktEINBLICKE
4 days ago
Innovation, Wachstum und Biotechnologie: Das Schweizer Unternehmen Lonza prägt die Life-Science-Industrie. Der jüngste Kapitalmarkttag spiegelte dies wider.
AD HOC NEWS
11 days ago
Lonza Group AG / CH0013841017
AD HOC NEWS
about 2 months ago
Lonza Group AG / CH0013841017
More Lonza News

Company Profile

Lonza Group AG engages in the supply of pharmaceutical, healthcare, and life science products. It operates through the following segments: Pharma & Biotech; Specialty Ingredients; and Corporate. The Pharma & Biotech segment comprises development and manufacture of customized active pharmaceutical ingredients and biopharmaceuticals as well as formulation services and delivery systems. The Specialty Ingredients segment consists of two divisions, consumer health and consumer resources and protection. The Corporate segment includes corporate functions, such as finance and accounting, legal, communication, information technology, and human resources. The company was founded in 1897 and is headquartered in Basel, Switzerland.

Head office Switzerland
CEO Wolfgang Wienand
Employees 18,000
Founded 1897
Website www.lonza.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today